Fibroblast growth factor receptor 4 (redirect from FGFR4)
receptor 4 (FGFR-4) is a protein that in humans is encoded by the FGFR4 gene. FGFR4 has also been designated as CD334 (cluster of differentiation 334)...
10 KB (1,291 words) - 09:08, 15 July 2024
vertebrates and all of them belong to the tyrosine kinase superfamily (FGFR1 to FGFR4). FGFR1 (see also Fibroblast growth factor receptor 1) (= CD331) FGFR2 (see...
8 KB (827 words) - 22:08, 3 December 2023
invasion. This growth factor is a high affinity, heparin dependent ligand for FGFR4. Expression of this gene was detected only in fetal but not adult brain...
21 KB (2,570 words) - 20:54, 5 June 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
73 KB (6,489 words) - 08:56, 21 December 2024
fibroblast growth factor receptor family has 4 members, FGFR1, FGFR2, FGFR3, and FGFR4. The FGFRs consist of three extracellular immunoglobulin-type domains (D1-D3)...
25 KB (3,124 words) - 21:38, 18 August 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
93 KB (8,733 words) - 03:33, 16 December 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
26 KB (2,420 words) - 02:40, 26 September 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
149 KB (15,719 words) - 16:46, 9 December 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
25 KB (1,825 words) - 05:46, 16 December 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
5 KB (412 words) - 23:17, 19 June 2023
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
121 KB (13,818 words) - 07:04, 26 December 2024
CSF1R FLT3 KIT PDGFR (PDGFRA PDGFRB) FGF receptor family FGFR1 FGFR2 FGFR3 FGFR4 VEGF receptors family VEGFR1 VEGFR2 VEGFR3 HGF receptor family MET RON Trk...
60 KB (6,879 words) - 14:26, 16 July 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
24 KB (2,882 words) - 16:31, 25 October 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
105 KB (12,331 words) - 00:34, 29 September 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
7 KB (492 words) - 08:38, 3 October 2024
CSF1R FLT3 KIT PDGFR (PDGFRA PDGFRB) FGF receptor family FGFR1 FGFR2 FGFR3 FGFR4 VEGF receptors family VEGFR1 VEGFR2 VEGFR3 HGF receptor family MET RON Trk...
9 KB (974 words) - 14:46, 22 June 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
28 KB (3,081 words) - 19:11, 28 November 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
11 KB (934 words) - 11:38, 21 October 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
42 KB (3,937 words) - 11:44, 15 November 2024
HGNC:23098 Q9NVK5 5655 FGFR2 HGNC:3689 P21802 5656 FGFR3 HGNC:3690 P22607 5657 FGFR4 HGNC:3691 P22455 5658 FGFRL1 HGNC:3693 Q8N441 5659 FGG HGNC:3694 P02679...
277 KB (17 words) - 18:41, 6 October 2024
dwarfism, seborrheic keratosis, bladder cancer and craniosynostosis CD334 FGFR4 (Fibroblast growth factor receptor 4). Although specific function is unknown...
96 KB (492 words) - 06:06, 25 November 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
17 KB (1,708 words) - 22:30, 15 October 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
70 KB (6,131 words) - 08:28, 27 December 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
13 KB (1,177 words) - 01:44, 4 November 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
22 KB (1,993 words) - 23:37, 23 March 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
34 KB (3,021 words) - 12:39, 5 August 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
16 KB (1,784 words) - 04:08, 6 January 2024
CSF1R FLT3 KIT PDGFR (PDGFRA PDGFRB) FGF receptor family FGFR1 FGFR2 FGFR3 FGFR4 VEGF receptors family VEGFR1 VEGFR2 VEGFR3 HGF receptor family MET RON Trk...
19 KB (2,341 words) - 00:54, 8 November 2023
EPHB3; EPHB4; EPHB6; ERBB2; ERBB3; ERBB4; FER; FES; FGFR1; FGFR2; FGFR3; FGFR4; FGR; FLT1; FLT3; FLT4; FRK; FYN; GSG2; HCK; IGF1R; ILK; INSR; INSRR; IRAK4;...
44 KB (5,283 words) - 12:50, 27 December 2024
Selpercatinib Sprifermin Trafermin Antibodies: Burosumab (against FGF23) FGFR4 Agonists: Ersofermin FGF (1, 2 (bFGF), 4, 6, 8, 9, 19) Trafermin Unsorted...
5 KB (334 words) - 22:50, 3 December 2023